1. P559 Real-life experience with long-term maintenance of golimumab in ulcerative colitis patients. (25th January 2019) Authors: Iborra, M; García-Morales, N; Rubio, S; Nantes Castillejo, O; Bertoletti, F; García-Planella, E; Calvo, M; Vera, I; Taxonera, C; Alba, C; Boscá-Watts, M; Martí-Aguado, D; Ballester Ferrer, M P; Sierra, M; Cano-Sanz, N; Mancenido, N; Pajares-Villarroya, R; Beltrán, B; Cañada, A; Nos, P Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P292 Association of golimumab trough concentrations during maintenance with endoscopic and histologic remission in patients with ulcerative colitis. (21st January 2022) Authors: Taxonera Samso, C; Fernández-Aceñero, M J; Olivares, D; Calvo, M; Casis, B; Bermejo, F; López Serrano, P; Iborra, M; Mesonero, F; Boscá Watts, M; Díaz del Arco, C; Vera, I; Olivares, S; Alba, C Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P114 SARS-CoV-2 infection in IBD: pandemic waves and predictors of severe or persistent COVID-19. (21st January 2022) Authors: Taxonera Samso, C; Olivares, D; Blanco, I; Velasco, E; Molina, S; López, G; López-García, O N; Alba, C; Rey, E Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P355 Preferences and satisfaction of IBD patients in whom the adalimumab regimen was changed from 40 mg weekly to 80 mg every other week: the ADASCAL study. (27th May 2021) Authors: Taxonera Samso, C; Martínez-Montiel, P; Barreiro-De-Acosta, M; Vera, I; Lorente, R; Vega, P; Diz-Lois, M T; Fuentes Coronel, A M; Pérez Calle, J L; Casis, B; Ferreiro, R; Calvo, M; Olivares, D; Alba, C Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU. (27th May 2021) Authors: Zabana Abdo, Y; Marín-Jiménez, I; Rodríguez-Lago, I; Ramírez Esteso, F; Meijilde, S; Ramos, L; Gomollón, F; Muñoz, F; Suris, G; Ortiz de Zárate, J; Huguet, J M; Llaó, J; García-Sepulcre, M; Sierra, M; Durà, M; Estrecha, S; Fuentes Coronel, A; Hinojosa, E; Olivan, L; Iglesias, E Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DOP31 Management and outcome of postoperative Crohn's Disease in the elderly as compared to young adults: Data from Eneida registry. (27th May 2021) Authors: Mañosa Ciria, M; Calafat, M; Ricart, E; Nos, P; Iglesias, E; Riestra, S; López-Sanroman, A; Vera, M; Guardiola, J; Hernández, V; Rivero, M; Carpio, D; Mínguez, M; Alba, C; Martín-Arranz, M D; Rodríguez, E; Gomollon, F; Garcia-López, S; Gutiérrez Casbas, A; Calvet, X Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S069 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P525 Real-world effectiveness and safety of ustekinumab in patients with ulcerative colitis: a systematic review and meta-analysis. (30th January 2023) Authors: Taxonera, C; Olivares, D; Olga N, L G; Alba, C Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗